ViroPharma Incorporated (VPHM)

[surf1944]

9:26AM ViroPharma's Buccolam granted European Marketing Authorization for treatment of acute seizures (VPHM) 18.61 : Co announces the European Commission has granted a Centralized Pediatric Use Marketing Authorization for Buccolam, for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years of age. This action by the European Commission represents the first product approval through the centralized PUMA procedure since its inception. In connection with the approval of Buccolam, co will make an additional payment of 10 mln Pounds Sterling (~$16.3 mln) to the former owners of Auralis